Bill Snyder

January 30, 2014

AIDS Clinical Trials Unit lands renewal of NIH funding

Vanderbilt University’s AIDS Clinical Trials Unit (ACTU) has received a seven-year grant renewal from the National Institutes of Health (NIH).

By Bill Snyder
January 24, 2014

Nine faculty honored with endowed chairs

Nine Vanderbilt University faculty members named to endowed chairs were honored for their academic achievements during a celebration Jan. 22 at the Student Life Center.

By Bill Snyder
Colleen Niswender
January 23, 2014

Autism Speaks grant boosts Rett syndrome research

Colleen Niswender, Ph.D., research associate professor of Pharmacology, has received a three-year, $450,000 grant from the autism science and advocacy organization Autism Speaks to support studies investigating a possible new treatment for Rett syndrome.

By Bill Snyder
January 23, 2014

UCSF’s Vale set to explore mechanisms of biological motility

Ron Vale, Ph.D., Lasker Award winner and co-discoverer of the molecular “motor” kinesin, will give the next Flexner Discovery Lecture at 4 p.m. on Thursday, Jan. 30, in 208 Light Hall.

By Bill Snyder
brain illustration
January 16, 2014

New approach may halt glioblastoma’s ability to grow

Vanderbilt University researchers have discovered a “backdoor” approach to blocking an enzyme that fuels the growth of glioblastoma, the most common and most fatal form of brain cancer.

By Bill Snyder
January 16, 2014

Awards honor dedicated efforts of research staff

Krassimira Garbett, Ph.D., Patricia “Cookie” Minton, R.N., and Kent Shaddox are the recipients of the 2013 Research Staff Awards at Vanderbilt University Medical Center.

By Bill Snyder
January 9, 2014

Pioneers of Discovery: Investigator seeks to debug cancer’s ‘bad software’

Beyond genetics — that’s the call Oliver McDonald, M.D., Ph.D., heard during the year between college and medical school he spent in a lab at St. Jude Children’s Research Hospital in Memphis.
By Bill Snyder
December 19, 2013

Ancient chemical bond may aid cancer therapy: study

A chemical bond discovered by Vanderbilt University scientists that is essential for animal life and which hastened the “dawn of the animal kingdom” could lead to new therapies for cancer and other diseases.
By Bill Snyder
December 19, 2013

VUMC positioned to meet challenges ahead: Balser

Jeff Balser, vice chancellor for health affairs and dean of the School of Medicine, announced Wednesday that workforce reduction efforts announced in September at Vanderbilt University Medical Center are completed.
By Bill Snyder
December 19, 2013

Biodegradable scaffold may spur wound healing

Biomedical and chemical engineers at Vanderbilt University, working with a pathologist, have constructed a sponge-like, biodegradable tissue “scaffold” that releases an enzyme-blocking molecule to indirectly activate endogenous pathways and enhance tissue regeneration and wound healing.
By Bill Snyder
December 18, 2013

VUMC positioned to meet challenges ahead: Balser

“The downsizing effort is over.” With those words, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the School of Medicine, announced Wednesday that workforce reduction efforts announced in September at Vanderbilt University Medical Center are completed.
By Bill Snyder
December 5, 2013

Day of events highlights efforts to fight diabetes

Vanderbilt University’s contributions to the field of diabetes — past and present — were celebrated recently during the annual Diabetes Day at the Vanderbilt Student Life Center.
By Bill Snyder